VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Unable to ambulate at least 150 feet prior to      │ Unable to ambulate at least 150 feet prior to      │     100 │
│ stroke, or experienced intermittent claudication   │ stroke, or experienced intermittent claudication   │         │
│ while walking                                      │ while walking                                      │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ history of congestive heart failure, unstable      │ history of congestive heart failure, unstable      │     100 │
│ cardiac arrhythmias, hypertrophic cardiomyopathy,  │ cardiac arrhythmias, hypertrophic cardiomyopathy,  │         │
│ severe aortic stenosis, angina or dyspnea at rest  │ severe aortic stenosis, angina or dyspnea at rest  │         │
│ or during ADL's                                    │ or during ADL's                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of oxygen dependence                       │ History of oxygen dependence                       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Preexisting neurological disorders, dementia or    │ Preexisting neurological disorders, dementia or    │     100 │
│ previous stroke                                    │ previous stroke                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of major head trauma                       │ History of major head trauma                       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Legal blindness or severe visual impairment        │ Legal blindness or severe visual impairment        │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ history of psychosis or other Axis I disorder that │ history of psychosis or other Axis I disorder that │     100 │
│ is primary                                         │ is primary                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Severe arthritis or other problems that limit      │ Severe arthritis or other problems that limit      │     100 │
│ passive range of motion                            │ passive range of motion                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of DVT or pulmonary embolism within 6      │ History of DVT or pulmonary embolism within 6      │     100 │
│ months                                             │ months                                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Uncontrolled diabetes with recent weight loss,     │ Uncontrolled diabetes with recent weight loss,     │     100 │
│ diabetic coma, or frequent insulin reactions       │ diabetic coma, or frequent insulin reactions       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ attempt of suicide in the last 2 years or at       │ attempt of suicide in the last 2 years or at       │     100 │
│ suicidal risk assessed by SCID interview           │ suicidal risk assessed by SCID interview           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Previous or current enrollment in a clinical trial │ Previous or current enrollment in a clinical trial │     100 │
│ to enhance motor recovery; 15) currently           │ to enhance motor recovery; 15) currently           │         │
│ exercising ≥ 2 times per week (≥20 minutes)        │ exercising ≥ 2 times per week (≥20 minutes)        │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Presence of non-MR compatible implants, pregnancy  │ Presence of non-MR compatible implants, pregnancy  │     100 │
│ or severe claustrophobia                           │ or severe claustrophobia                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ 1) age 50-70                                       │ age 50-70                                          │      86 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ 7) HRSD question #9 regarding suicide \<2          │ HRSD question #9 regarding suicide <2              │      95 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ 2) stroke within the past 6 to 60 months           │ stroke within the past 6 to 60 months              │      96 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ 4) residual paresis in the lower extremity (Fugl-  │ residual paresis in the lower extremity (Fugl-     │      97 │
│ Meyer LE motor score \<34)                         │ Meyer LE motor score <34)                          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ 6) no antidepressant medications or clinically     │ no antidepressant medications or clinically able   │      98 │
│ able to discontinue medications                    │ to discontinue medications                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Life expectancy \<1 yr                             │ Life expectancy <1 yr                              │      98 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ 3) major depressive disorder (PHQ-9 \> 10) and     │ major depressive disorder (PHQ-9 > 10) and         │      99 │
│ diagnosed using the Structured Clinical Interview  │ diagnosed using the Structured Clinical Interview  │         │
│ for Depression (SCID) according to the Diagnostic  │ for Depression (SCID) according to the Diagnostic  │         │
│ and Statistical Manual of Mental Disorders, Fourth │ and Statistical Manual of Mental Disorders, Fourth │         │
│ Edition (DSM-IV)                                   │ Edition (DSM-IV)                                   │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ 5) ability to walk without assistance and without  │ ability to walk without assistance and without an  │      99 │
│ an AFO on the treadmill ≥ 30 seconds at speeds     │ AFO on the treadmill ≥ 30 seconds at speeds        │         │
│ ranging from 0.2-0.8 m/s                           │ ranging from 0.2-0.8 m/s                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ 8) provision of informed consent. In addition, all │ provision of informed consent. In addition, all    │      99 │
│ subjects who meet criteria for the training        │ subjects who meet criteria for the training        │         │
│ portion must complete an exercise tolerance test   │ portion must complete an exercise tolerance test   │         │
│ and be cleared for participation by the study      │ and be cleared for participation by the study      │         │
│ cardiologist                                       │ cardiologist                                       │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Severe hypertension with systolic \>200 mmHg and   │ Severe hypertension with systolic >200 mmHg and    │      99 │
│ diastolic \>110 mmHg at rest                       │ diastolic >110 mmHg at rest                        │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤═══════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                         │   Score │
╞═══════════════════════════════════╪═══════════════════════════════════════╪═════════╡
│ Must have minimum age of 50 Years │ stroke within the past 6 to 60 months │      40 │
├───────────────────────────────────┼───────────────────────────────────────┼─────────┤
│ Must have maximum age of 70 Years │ stroke within the past 6 to 60 months │      40 │
╘═══════════════════════════════════╧═══════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 97
Average Levenshtein Ratio of individual lines: 93.84
OverAll Ratio: 95.42
